Literature DB >> 14661539

[Molecular mechanism for choroidal neovascularization in age-related macular degeneration].

Kyoko Ohno-Matsui1.   

Abstract

Choroidal neovascularization (CNV) in age-related macular degeneration (AMD) is the most common cause of severe visual loss in patients over age 60 years in developed countries. While much is unknown about the underlying pathogenesis of CNV, the increased production of vascular endothelial growth factor(VEGF) by retinal pigment epithelium (RPE) is thought to play a central role in the development of this condition. However, recent studies using gene-manipulated mice question the importance of VEGF alone in promoting CNV. Angiogenesis is thought to result from the balance between angiogenesis stimulation and inhibition. A potent antiangiogenic factor recently has been identified in the retina and shown to be secreted by RPE cells. The inhibitor, pigment epithelium-derived factor(PEDF) is considered the key factor associated with avascularity of the cornea, vitreous, and outer retinal layer of the eye. We recently demonstrated that an imbalance between PEDF and VEGF in RPE cells caused by aging and oxidative stress may contribute to the disregulation of endothelial cell proliferation in CNV. In this review, we also discuss the angiogenic role of inflammatory cells in CNV, age-related changes in Bruch's membrane, and the possibility of the development of animal models reflecting CNV in AMD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661539

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  6 in total

1.  Proteomic Analysis of Embryonic and Young Human Vitreous.

Authors:  Kenneth M P Yee; Edward P Feener; Michele Madigan; Nicholas J Jackson; Ben-Bo Gao; Fred N Ross-Cisneros; Jan Provis; Lloyd Paul Aiello; Alfredo A Sadun; J Sebag
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

Review 2.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Authors:  P Fernández-Robredo; A Sancho; S Johnen; S Recalde; N Gama; G Thumann; J Groll; A García-Layana
Journal:  J Ophthalmol       Date:  2014-01-14       Impact factor: 1.909

3.  Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice.

Authors:  Tuhina Prasad; Ping Zhu; Amrisha Verma; Paramita Chakrabarty; Awilda M Rosario; Todd E Golde; Qiuhong Li
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

4.  Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids.

Authors:  Gabriele Thumann; Nina Harmening; Cécile Prat-Souteyrand; Corinne Marie; Marie Pastor; Attila Sebe; Csaba Miskey; Laurence D Hurst; Sabine Diarra; Martina Kropp; Peter Walter; Daniel Scherman; Zoltán Ivics; Zsuzsanna Izsvák; Sandra Johnen
Journal:  Mol Ther Nucleic Acids       Date:  2017-02-10       Impact factor: 8.886

5.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

6.  Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.

Authors:  ShiHong Zhao; LiNa Huang; JinHui Wu; Yuan Zhang; DongYan Pan; Xin Liu
Journal:  Mol Vis       Date:  2009-06-17       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.